TFFP Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TFFP shares is 23, representing 24.37% of the company's common stock.

PRINCETON CAPITAL MANAGEMENT LLC, in the last quarter, reduced its stake in TFFP by -11.25% restricting it's holding to 18.16 thousand shares of worth nearly $6.36K. VANGUARD GROUP INC also lessened -0.79% of the TFFP shares from its portfolio, reducing its holding to 846.88 thousand shares of worth $296.41K. BANK OF AMERICA CORP /DE/ also shunned TFFP shares holding by -25.86% last quarter which brought its holding to 2.51 thousand shares worth $878.00.

As per its latest 13F filing, VIRTU FINANCIAL LLC increased its stake in TFFP by 100% in the last quarter. The institutional holder raised its holding to 15.76 thousand shares having worth more than $6.00K. JANNEY MONTGOMERY SCOTT LLC also added 100% more shares of TFFP to its portfolio, raising its holding to 14.35 thousand shares of worth $5.00K. TOWER RESEARCH CAPITAL LLC (TRC) also increased its TFFP shares holding by 17.21% which brought its holding to 13.88 thousand shares worth $4.86K.

The insider with the most stakes in TFFP is CARLSON CAPITAL L P , 10 percent owner at the company. Additionally, TFFP stock is highly held by 10 percent owner Lung Therapeutics, Inc. and President and CEO Weisman Harlan F among others.

Company executives, directors, and other insiders own 3.31% percent of TFF Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which TFFP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include CARLSON CAPITAL L P, THURMAN RANDY H, and LUNG THERAPEUTICS, INC..

There have been 0 transaction(s) during the past 6-months in which TFF Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 0 TFF Pharmaceuticals, Inc. shares are held by insiders, which represents about 3.31% of TFFP stock.

TFFP 10 percent owner, CARLSON CAPITAL L P holds the largest portfolio of the company's shares. TFFP shares owned by CARLSON total nearly 5.06 million.

PRINCETON CAPITAL MANAGEMENT LLC is the largest institutional owner in TFFP which holds 18.16 thousand shares worth $6.36K or 0.05% of the total TFFP shares outstanding followed by VIRTU FINANCIAL LLC with ownership of 15.76 thousand shares representing 0.04% of the TFFP ownership. JANNEY MONTGOMERY SCOTT LLC is the third largest stakeholder with 14.35 thousand shares or 0.04% of the ownership worth more than $5.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TFFP is concerned, it is a stock which is not optionable.

Number of TFFP shares short is 171.96K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 4.44M shares of TFFP are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TFFP has 2.80M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TFFP is 1.77.